QQ客服 官方微博 反馈留言

浏览/检索结果: 共12条，第1-10条 帮助 限定条件 发表日期：2016     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Clarithromycin Interacts with Lenalidomide in the Combination Regimen Bird and Overcomes Drug Resistance in Multiple Myeloma 期刊论文 BLOOD, 2016, 卷号: 128, 期号: 22 作者:  Jin, Fengyan;  Li, Shuang;  Chen, Lijuan;  Wu, Chuan;  Li, Wei 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 Curative Efficacy of Lenalidomide plus Low Dose Dexamethasone for Multiple Myeloma]. 期刊论文 Zhongguo shi yan xue ye xue za zhi, 2016, 卷号: 24, 页码: 498-501 作者:  Liu Hai-Bo;  Chen Li-Mei 收藏  |  浏览/下载：1/0  |  提交时间：2019/11/26 Impact of renal impairment on outcomes with lenalidomide and dexamethasone treatment in the FIRST trial, a randomized, open-label phase 3 trial in transplant-ineligible patients with multiple myeloma 期刊论文 Haematologica, 2016, 卷号: Vol.101 作者:  M. A. Dimopoulos;  M. C. Cheung;  M. Roussel;  T. Liu;  B. Gamberi 收藏  |  浏览/下载：3/0  |  提交时间：2019/02/25 myelodysplastic syndromes  multiple myeloma  quality of life   Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis 期刊论文 PLOS ONE, 2016, 卷号: 11, 期号: 11, 页码: e0165948 作者:  Lian, Xin-yue[1];  Zhang, Zhi-hui[2];  Deng, Zhao-qun[3];  He, Pin-fang[4];  Yao, Dong-ming[5] 收藏  |  浏览/下载：16/0  |  提交时间：2019/12/24 THE FIRST TRIAL: ANALYSIS OF THE ASIAN SUBGROUP OF TRANSPLANT-INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CONTINUOUS LENALIDOMIDE AND LOW-DOSE DEXAMETHASONE 会议论文 HAEMATOLOGICA, 2016-06-01 作者:  Lu, J.;  Lee, J. H.;  Huang, S. Y.;  Qiu, L.;  Lee, J. J. 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/04 IXAZOMIB PLUS LENALIDOMIDE-DEXAMETHASONE (IRD) VS PLACEBO-RD IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): CHINA CONTINUATION OF TOURMALINE-MM1 会议论文 HAEMATOLOGICA, 2016-06-01 作者:  Hou, J.;  Jin, J.;  Xu, Y.;  Wu, D.;  Ke, X. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 IXAZOMIB PLUS LENALIDOMIDE-DEXAMETHASONE (IRD) VS PLACEBO-RD IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): CHINA CONTINUATION OF TOURMALINE-MM1 期刊论文 2016, 卷号: 101, 页码: 540-540 作者:  Hou, J.;  Jin, J.;  Xu, Y.;  Wu, D.;  Ke, X. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/04 Ixazomib plus lenalidomide-dexamethasone (IRd) vs placebo-Rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM): China continuation of TOURMALINE-MM1. 期刊论文 2016, 卷号: 34, 期号: 15 作者:  Hou, Jian;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone 期刊论文 2016, 卷号: 11, 期号: 1, 页码: 80 作者:  Yang, Hongbo;  Huang, Xufei;  Cai, Qianqian;  Wang, Chen;  Cao, Xinxin 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04 POEMS syndrome  Lenalidomide  Sexual function  Hypogonadism   Ixazomib plus lenalidomide-dexamethasone (IRd) vs placebo-Rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM): China continuation of TOURMALINE-MM1. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Hou, Jian;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04